Cargando…
Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus
BACKGROUND: Platelets in patients with type 2 diabetes mellitus (DM2) are characterized by increased activation and aggregation, which tends to be associated with a high morbidity and mortality due to cardiovascular disease (CVD). Moreover, a large proportion of DM2 patients show an inadequate respo...
Autores principales: | Zhou, Ai-ming, Xiang, Yi-jia, Liu, En-qian, Cai, Chang-hong, Wu, Yong-hui, Yang, Le-bing, Zeng, Chun-lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956554/ https://www.ncbi.nlm.nih.gov/pubmed/31931718 http://dx.doi.org/10.1186/s12872-019-01316-z |
Ejemplares similares
-
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
por: Wu, Jia-Zhen, et al.
Publicado: (2019) -
Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation
por: Yuan, Xiaoling, et al.
Publicado: (2017) -
Influence of Chitosan Nanoparticles as the Absorption Enhancers on Salvianolic acid B In vitro and In vivo Evaluation
por: Jin, Xin, et al.
Publicado: (2016) -
Neuroprotective Effect of Salvianolic Acids against Cerebral Ischemia/Reperfusion Injury
por: Hou, Shuai, et al.
Publicado: (2016) -
Inhibition of Tanshinone IIA, Salvianolic Acid A and Salvianolic Acid B on Areca Nut Extract-Induced Oral Submucous Fibrosis in Vitro
por: Dai, Jian-Ping, et al.
Publicado: (2015)